Simon M M, Ali S, Tewari R, Simon H G, Müller-Hermelink H K, Epplen J T
Eur J Immunol. 1986 Oct;16(10):1269-76. doi: 10.1002/eji.1830161014.
In spite of many promising attempts to apply T cell clones to questions of in vitro and in vivo function of T cells it is still unclear to what extent continuous propagation of T lymphocytes in vitro effects their original properties. This study describes the appearance of malignant cells from long-term cultured C57BL/6 (B6) cytotoxic T lymphocytes (CTL). Four out of five T cell lines (CTLL.1,3,4,5) representing distinct stages of development of T effector cells in vitro were repeatedly cloned and all five CTLL were tested for various cellular parameters. It is shown that transformation of H-Y-specific CTLL into malignant cells in vitro was accompanied by alterations in growth characteristics, successive loss of specificity and cytolytic function and by quantitative changes in the expression of cell surface markers. Whereas growth of the H-Y-specific CTLL (CTLL.1) was dependent on antigen and concanavalin A (Con A) supernatant (Con ASN) the CTLL variants could be either maintained in Con ASN alone (CTLL.3) or in the absence of both antigen and lymphokine sources (CTLL.4,5). CTLL.1 was cytolytic for male B6 target cells and lysed P815 tumor targets in the presence but not the absence of lectin. In contrast, CTLL.3 lost its original specificity but lysed P815 cells in the absence or presence of lectin. CTLL.2 representing an intermediary stage showed cytolytic activity on both male B6 and P815 target cells. In contrast, CTLL.4 and CTLL.5 lost the ability to lyse any of the indicated target cells. Although all CTLL expressed the surface markers Thy-1, Lyt-2, Kb, Db and interleukin 2 receptor (IL 2 R), Thy-1 and Lyt-2 markers were drastically reduced and Kb/Db and IL 2 R structures significantly increased on CTLL.4 and CTLL.5 compared to CTLL.1,2,3. In addition, multiple karyotypic alterations including the appearance of metacentric chromosomes were observed in long-term cultured CTLL. Investigations on the expression of the alpha-, beta-, and gamma-chains of the T cell antigen receptor in CTLL.1-5 indicate that all three chains were expressed as mRNA irrespective of whether the lymphocytes expressed their original specificity and/or function. However, distinct beta variable chain genes were used by H-Y-specific CTLL and its long-term culture variants CTLL.2 and CTLL.3 suggesting that the expression of the new specificity was accompanied by the rearrangement of a new beta-chain gene in T effector cells.(ABSTRACT TRUNCATED AT 400 WORDS)
尽管人们为将T细胞克隆应用于T细胞体外和体内功能的研究进行了许多有前景的尝试,但目前仍不清楚T淋巴细胞在体外的持续传代对其原始特性的影响程度。本研究描述了长期培养的C57BL/6(B6)细胞毒性T淋巴细胞(CTL)中恶性细胞的出现。代表T效应细胞体外不同发育阶段的五个T细胞系(CTLL.1、3、4、5)中有四个被反复克隆,并对所有五个CTLL进行了各种细胞参数测试。结果表明,H-Y特异性CTLL在体外转化为恶性细胞伴随着生长特性的改变、特异性和细胞溶解功能的相继丧失以及细胞表面标志物表达的定量变化。H-Y特异性CTLL(CTLL.1)的生长依赖于抗原和伴刀豆球蛋白A(Con A)上清液(Con ASN),而CTLL变体可以单独维持在Con ASN中(CTLL.3),或者在既无抗原又无淋巴因子来源的情况下维持(CTLL.4、5)。CTLL.1对雄性B6靶细胞具有细胞溶解作用,在有凝集素存在而非不存在时能裂解P815肿瘤靶细胞。相比之下,CTLL.3失去了其原始特异性,但在有无凝集素的情况下都能裂解P815细胞。代表中间阶段的CTLL.2对雄性B6和P815靶细胞均表现出细胞溶解活性。相反,CTLL.4和CTLL.5失去了裂解任何上述靶细胞的能力。尽管所有CTLL都表达表面标志物Thy-1、Lyt-2、Kb、Db和白细胞介素2受体(IL 2 R),但与CTLL.1、2、3相比,CTLL.4和CTLL.5上的Thy-1和Lyt-2标志物显著减少,而Kb/Db和IL 2 R结构显著增加。此外,在长期培养的CTLL中观察到多种核型改变,包括中着丝粒染色体的出现。对CTLL.1 - 5中T细胞抗原受体α、β和γ链表达的研究表明,无论淋巴细胞是否表达其原始特异性和/或功能,所有三条链均以mRNA形式表达。然而,H-Y特异性CTLL及其长期培养变体CTLL.2和CTLL.3使用了不同的β可变链基因,这表明新特异性的表达伴随着T效应细胞中新β链基因的重排。(摘要截断于400字)